This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodrich, J. S.
Right arrow Articles by Gilligan, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodrich, J. S.
Right arrow Articles by Gilligan, P. H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2009, p. 1231-1233, Vol. 47, No. 4
0095-1137/09/$08.00+0     doi:10.1128/JCM.00255-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Prevalence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Patients with Cystic Fibrosis{triangledown}

Jennifer S. Goodrich,1 Tameaka N. Sutton-Shields,1 Alan Kerr,1 Joel P. Wedd,2 Melissa B. Miller,1,3 and Peter H. Gilligan1,3*

Clinical Microbiology-Immunology Laboratories, University of North Carolina Hospitals,1 University of North Carolina School of Public Health,2 Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina3

Received 5 February 2009/ Accepted 10 February 2009

We prospectively determined the prevalence of community-associated Staphylococcus aureus in a large cystic fibrosis (CF) center between October 2005 and October 2007. We found that 2.7% (19/707) of the CF patients who had cultures during the study period were infected with this organism, representing 14% of the total methicillin-resistant Staphylococcus aureus strains (n = 140) recovered from the patient population during the study period.


* Corresponding author. Mailing address: Clinical Microbiology-Immunology Laboratories, UNC Hospitals, CB 7600, Chapel Hill, NC 27514. Phone: (919) 966-6313. Fax: (919) 966-0486. E-mail: pgilliga{at}unch.unc.edu

{triangledown} Published ahead of print on 18 February 2009.


Journal of Clinical Microbiology, April 2009, p. 1231-1233, Vol. 47, No. 4
0095-1137/09/$08.00+0     doi:10.1128/JCM.00255-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.